#tirzepatide

[ follow ]
fromPsychology Today
1 day ago

Body Image in the Ozempic Era

Before I explain, I want to clarify that I firmly believe in body autonomy. If someone chooses to take a weight loss medication, they should be able to do so without judgment. I hope all potential users are fully informed about the risks and benefits of these medications and are followed responsibly by medical providers. Ideally, they would also be screened for a current or past eating disorder or any other condition that might contraindicate the use of GLP-1s and GIPs.
Medicine
Medicine
fromHarvard Gazette
1 week ago

Weight-loss drugs reduce risk of heart failure by 40% - Harvard Gazette

Semaglutide or tirzepatide initiation is associated with over 40% lower risk of hospitalization or death in high-risk HFpEF patients with obesity and Type 2 diabetes.
Medicine
fromwww.theguardian.com
1 week ago

Weight loss drugs can halve heart patients' risk of early death, study finds

GLP-1 agonist weight-loss drugs substantially reduce hospitalization and premature death risk in obese heart failure patients with type 2 diabetes, up to 58%.
Medicine
fromwww.theguardian.com
1 week ago

Eli Lilly pauses shipments of weight loss drug Mounjaro to UK

Eli Lilly paused UK shipments of Mounjaro ahead of up-to-170% September price rise, imposing allocations to manage supply and prevent stockpiling.
fromScienceDaily
1 month ago

Weight-loss wonder drug Mounjaro/Zepbound shrinks breast cancer tumors

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model.
Health
Cancer
fromScienceDaily
1 month ago

Tirzepatide: The weight-loss drug that also shrinks breast tumors in mice

Tirzepatide induces significant weight loss and reduces breast cancer tumor growth in obese mice, suggesting potential anti-cancer benefits of next-generation weight-loss drugs.
Health
fromScienceDaily
1 month ago

Hormone therapy supercharges tirzepatide, unleashing major weight loss after menopause

Combination therapy of tirzepatide and hormone therapy promotes greater weight loss in postmenopausal women than tirzepatide alone.
fromwww.npr.org
4 months ago

Eli Lilly sues companies selling alternative versions of its weight loss drug

Eli Lilly is suing four telehealth companies for selling illegal copies of its weight-loss drug Zepbound, which is based on the active ingredient tirzepatide.
Alternative medicine
Alternative medicine
fromWIRED
4 months ago

Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs

FDA allowed compounding pharmacies a grace period to cease production post-drug shortage, but some continue to sell modified tirzepatide products.
[ Load more ]